Health Care · Surgical & Medical Instruments & Apparatus

DCTH DELCATH SYSTEMS, INC. SEC Filings & Insider Trading Activity 2026

company
CIK 872912110 filings
Russell 2000

DCTH at a glance

DELCATH SYSTEMS, INC. (DCTH, SEC CIK 872912) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 9, 2026, an 8-K current report on November 9, 2026 and Form 4 insider filings as recently as November 13, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.

  • For the fiscal year ended December 31, 2025 (FY2025), DELCATH SYSTEMS, INC. (DCTH) reported revenue of $85.2 million (up 129.1% from FY2024) and net income of $2.7 million. Diluted EPS was $0.07.
  • As of September 30, 2026, 24 institutional investment managers tracked by SignalX reported holding DELCATH SYSTEMS, INC. (DCTH) shares worth $148.7 million in 13F-HR filings.
  • The most recent insider open-market sale reported on Form 4 was by Martell Bridget A on November 12, 2026 of 1,930 shares at $22.26 per share.
  • In the last 90 days, DCTH insiders reported 0 open-market purchases ($0) and 2 open-market sales ($489K) on Form 4, a net sale of $489K.

Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).

Revenue · FY2025
$85.2M
+129.1% vs prior year
Insiders · 90 days
0 buys · 2 sells
Net −$489K
13F holders
24 funds
$148.7M · +1 vs prior quarter
Latest 8-K
Nov 9, 2026
Item 2.02

AI 10-Q Quarterly Report Analysis

Latest 10-Q, quarter ended Sep 30, 2026

Management Discussion & Analysis

  • Revenue $35.1M, up $14.5M YoY from $20.6M, driven by HEPZATO commercial expansion
  • Operating margin 20.3% vs negative 1.9% YoY, operating income $7.1M vs $(0.4)M
  • Best performer HEPZATO KIT: $32.7M revenue vs $19.3M, CHEMOSAT $2.4M vs $1.3M
  • Operating cash flow $14.7M vs $14.3M YoY, cash and equivalents $55.5M plus investments $48.8M
  • Outlook: liquidity expected to fund operations at least 12 months, Phase 2 trial expenses expected to increase

Risk Factors

  • No material changes from the Annual Report, with business, financial condition, and results of operations exposed to disclosed risks
  • Unknown or currently immaterial risks could significantly impair operations, financial condition, or results
  • Common-stock market price could decline, potentially causing investors to lose all or part of their investment

AI summary of the DCTH 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K

AI 8-K Current Report Analysis

The most recent material events, by 8-K item

Filed Nov 9, 2026Full analysis →

Item 2.02: Results of Operations and Financial Condition

  • Delcath announced third-quarter 2026 financial results and business highlights for the quarter ended September 30, 2026
  • Exhibit 99.1 contains the substantive results and operating update investors should review

Item EX-99.1: Item EX-99.1

  • Q3 revenue $35.1M, up from $20.6M, led by HEPZATO revenue of $32.7M
  • Net income $7.0M versus $0.8M, with adjusted EBITDA $11.5M versus $5.3M
Filed Aug 14, 2026Full analysis →

Item 5.03: Amendments to Articles of Incorporation or Bylaws

  • Bylaws amended August 12, 2026, effective immediately, by board action
  • Delaware Chancery Court designated exclusive forum for internal corporate claims
Filed Aug 6, 2026Full analysis →

Item EX-99.1: Item EX-99.1

  • Q2 revenue rose to $29.1M from $24.2M, led by HEPZATO KIT revenue of $27.1M
  • Gross margin expanded to 90% from 86%, supporting strong product economics

Item 2.02: Results of Operations and Financial Condition

  • Press release announces Delcath’s financial results for the quarter ended June 30, 2026
  • Business highlights accompany the quarterly results, with details contained in Exhibit 99.1

AI summaries of DCTH 8-K current reports filed with the SEC. What 8-K item codes mean

SignalX for DCTH

Don't miss the next DCTH filing

  • Alerts as it files. A push when DCTH files an 8-K or an insider trades.
  • Fund moves. Which tracked funds opened, added or cut DCTH, by share count.
  • Ask anything. An AI agent that reads every DCTH filing and answers with sources.

DCTH alerts on your phone. Follow it in the SignalX Android app.

Get it on Google Play

Recent Insider Transactions (Form 4)

Latest reported trades by officers, directors and 10% owners

InsiderTypeDatePrice
Martell Bridget AMNov 12, 2026$7.85
Martell Bridget AMNov 12, 2026-
Martell Bridget ASellNov 12, 2026$22.26
Martell Bridget ASellNov 12, 2026$21.66
Rosalind Advisors, Inc.JOct 13, 2026-
Rosalind Advisors, Inc.COct 13, 2026-
Rosalind Advisors, Inc.COct 13, 2026-
Sylvester John RichardAMay 13, 2026-

Financial Summary
XBRL

Annual financial summary from SEC XBRL data
MetricFY2023FY2024FY2025
Profitability
Revenue-$37.2M$85.2M
Gross Profit-$31.0M$73.4M
Operating Income--$12.4M$660K
Net Income--$26.4M$2.7M
Gross Margin-83.4%86.2%
Op. Margin--33.4%0.8%
Net Margin--70.9%3.2%
Balance Sheet
Total Assets$38.6M$76.6M$123.6M
Equity-$68.7M$111.2M
ROE--38.4%2.4%
Per Share
EPS-$-0.93$0.07
Cash Flow
Operating CF--$18.7M$22.5M
CapEx$58K$559K$1.5M

Source: XBRL data in DELCATH SYSTEMS, INC. (DCTH)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →

13F Fund Holdings: Quarterly Trend

Latest: Q3 2026

Aggregate DCTH share value held by 13F filers tracked by SignalX, by quarter.

Quarterly totals table
DCTH shares held by 13F filers tracked by SignalX, by quarter
QuarterFundsTotal value
Q3 202624$148.7M
Q2 202623$88.3M
Q1 202621$55.5M
Q4 202519$66.9M
Q3 202521$68.1M
Q2 202521$93.6M
Q1 202513$44.4M
Q4 20249$28.3M
Position changes: Q2 2026 → Q3 2026
Top Buyers
Top Sellers
New Positions
Closed Positions

Source: 13F-HR filings on SEC EDGAR (aggregated from 151 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work

DCTH filing archive

AI analysis pages for each 10-K, 10-Q and 8-K

Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4

FormFiling dateAnalysisSEC
4Nov 13, 2026--
10-QNov 9, 2026Analysis
8-KNov 9, 2026Analysis-
4Oct 14, 2026--
8-KAug 14, 2026Analysis-
10-QAug 6, 2026Analysis
8-KAug 6, 2026Analysis-
SC 13GJul 28, 2026-
8-KMay 14, 2026Analysis
4May 14, 2026-
4May 14, 2026-
4May 14, 2026-
4May 14, 2026-
4May 14, 2026-
8-KMay 7, 2026Analysis
10-QMay 7, 2026Analysis
SC 13GMar 20, 2026-
4Mar 6, 2026--
8-KMar 3, 2026Analysis-
4Mar 3, 2026--
8-KFeb 26, 2026Analysis-
10-KFeb 26, 2026-
4Feb 18, 2026-
4Feb 18, 2026-
4Feb 18, 2026-

Related Health Care companies

All Health Care →

DCTH SEC filings: frequently asked questions

Are DCTH insiders buying or selling?

In the last 90 days, DELCATH SYSTEMS, INC. (DCTH) officers, directors and 10% owners reported no open-market purchases and 2 open-market sales worth $488,508 by 1 insider on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.

Which institutions hold DCTH stock?

As of September 30, 2026, the largest DELCATH SYSTEMS, INC. (DCTH) holders among the 13F filers tracked by SignalX were BlackRock ($63.8 million), Vanguard Capital Management LLC ($19.6 million), State Street Corp ($12.1 million), Millennium Management ($9.7 million), Morgan Stanley ($8.8 million). 13F-HR reports are filed up to 45 days after each quarter ends.

What was DCTH's revenue in fiscal year 2025?

For the fiscal year ended December 31, 2025 (FY2025), DELCATH SYSTEMS, INC. (DCTH) reported revenue of $85.2 million (up 129.1% from FY2024) and net income of $2.7 million. Diluted EPS was $0.07. The figures come from the XBRL data in the 10-K.

What did DCTH report in its latest 8-K?

DELCATH SYSTEMS, INC. (DCTH) filed an 8-K on November 9, 2026 reporting Item 2.02 (Results of Operations and Financial Condition). Delcath announced third-quarter 2026 financial results and business highlights for the quarter ended September 30, 2026.

What are the latest DCTH SEC filings?

DELCATH SYSTEMS, INC. (DCTH) filed its latest 10-K annual report on February 26, 2026, a 10-Q quarterly report on November 9, 2026, an 8-K current report on November 9, 2026 and a Form 4 insider filing on November 13, 2026.

What is DCTH's SEC CIK number?

DELCATH SYSTEMS, INC. (DCTH)'s SEC Central Index Key (CIK) is 872912. EDGAR lists every DCTH filing under that number.

Ask anything about DCTH

The research agent reads DCTH's filings, financials, insider trades and 13F holders, then answers with sources.